Moderna is deprioritizing its flu/COVID combination vaccine in younger adults amid a push to cut about $1.5 billion from its ...

A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...

THURSDAY, May 8, 2025 (HealthDay News) — A new vaccine that combines flu and COVID ... Moderna said it now expects that approval of the shot may not come until 2026. “I agree in this case ...

Additional data required by the FDA are the latest evidence of what one analyst described as a “higher bar” for vaccines.

Researchers from vaccine-maker Moderna reported in a study published Wednesday that the new combo shot generated a stronger immune response against COVID-19 ... agree in this case with FDA that ...

Moderna said on Thursday it now does not expect regulatory approval for its combination flu/COVID-19 shot until 2026, after the FDA said it required late-stage data demonstrating the shot's ...

Moderna researchers reported that the combo shot produced a stronger immune response against COVID-19 and most flu ... “I agree in this case with FDA that efficacy data are important to see ...

Researchers from vaccine-maker Moderna reported in a study published Wednesday that the new combo shot generated a stronger immune response against COVID-19 ... agree in this case with the FDA ...